Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2013
Geriatric factors predict chemotherapy feasibility: ancillary results of FFCD 2001-02 phase III study in first-line chemotherapy for metastatic colorectal cancer in elderly patientsThomas Aparicio, Jean-Louis Jouve, Laurent Teillet, et al.
The Lancet. Oncology|September 10, 2011
Sequential versus combination chemotherapy for the treatment of advanced colorectal cancer (FFCD 2000-05): an open-label, randomised, phase 3 trialMichel Ducreux, David Malka, Jean Mendiboure, et al.
European Journal of Cancer (Oxford, England : 1990)|September 22, 2014
Gemcitabine plus cisplatin versus chemoradiotherapy in locally advanced biliary tract cancer: Fédération Francophone de Cancérologie Digestive 9902 phase II randomised studyJean-Marc Phelip, Véronique Vendrely, Florian Rostain, et al.
The American Journal of Pathology|March 14, 2015
Transcriptomic analysis predicts survival and sensitivity to anticancer drugs of patients with a pancreatic adenocarcinomaPauline Duconseil, Marine Gilabert, Odile Gayet, et al.
European Journal of Cancer (Oxford, England : 1990)|May 29, 2018
Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trialsThomas Aparicio, Michel Ducreux, Roger Faroux, et al.
Oncotarget|December 8, 2014
A subgroup of pancreatic adenocarcinoma is sensitive to the 5-aza-dC DNA methyltransferase inhibitorOdile Gayet, Celine Loncle, Pauline Duconseil, et al.
British Journal of Cancer|February 5, 2020
Predictive factors for early progression during induction chemotherapy and chemotherapy-free interval: analysis from PRODIGE 9 trialThomas Aparicio, Jaafar Bennouna, Karine Le Malicot, et al.
Oncotarget|July 28, 2016
A pancreatic ductal adenocarcinoma subpopulation is sensitive to FK866, an inhibitor of NAMPTMarine Barraud, Jonathan Garnier, Celine Loncle, et al.
Gut|November 30, 2019
Artificial intelligence-guided tissue analysis combined with immune infiltrate assessment predicts stage III colon cancer outcomes in PETACC08 studyCynthia Reichling, Julien Taieb, Valentin Derangere, et al.
European Journal of Cancer (Oxford, England : 1990)|November 10, 2016
Geriatric factors analyses from FFCD 2001-02 phase III study of first-line chemotherapy for elderly metastatic colorectal cancer patientsThomas Aparicio, Dany Gargot, Laurent Teillet, et al.
Pageof 5